PIPE Investors
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$333.1M
Focus Areas
2
Top Stage
Phase 3
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| LENZ Therapeutics | $327.9M |
| Talis Biomedical | $5.2M |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| LENZ Therapeutics | $327.9M |
| Talis Biomedical | $5.2M |